Ronald A. Cantrell, Ph.D.
Affiliations: | 2008 | Epidemiology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Public Health, EpidemiologyGoogle:
"Ronald Cantrell"Cross-listing: PHTree
Parents
Sign in to add mentor| Donna Arnett | grad student | 2008 | UAB | |
| (Diagnosing antiretroviral treatment failure in resource-limited settings.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Koethe JR, Westfall AO, Luhanga DK, et al. (2010) A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. Plos One. 5: e9680 |
| Chi BH, Cantrell RA, Mwango A, et al. (2010) An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. American Journal of Epidemiology. 171: 924-31 |
| Chi BH, Ellis GM, Chintu N, et al. (2009) Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention. Aids Research and Human Retroviruses. 25: 1099-106 |
| Chi BH, Cantrell RA, Zulu I, et al. (2009) Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. International Journal of Epidemiology. 38: 746-56 |
| Mulenga LB, Kruse G, Lakhi S, et al. (2008) Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. Aids (London, England). 22: 1821-7 |
| Goldman JD, Cantrell RA, Mulenga LB, et al. (2008) Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. Aids Research and Human Retroviruses. 24: 1031-5 |
| Chi BH, Chintu N, Cantrell RA, et al. (2008) Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 220-3 |
| Krebs DW, Chi BH, Mulenga Y, et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. Aids Care. 20: 311-7 |
| Chi BH, Sinkala M, Mbewe F, et al. (2007) Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet. 370: 1698-705 |
| Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Jama. 298: 1888-99 |